Behavioral Research to Improve Medication-Based Treatment

Overview

The Research Need

Medication-based treatment is an established and effective intervention for people with opioid use disorder (OUD). Medications for people with OUD include methadone, buprenorphine/naloxone, buprenorphine, and naltrexone. However, the people who would benefit from these medications often do not receive them or stay on them only a short time, which limits their chances for long-term recovery.

About the Program

The goal of the Behavioral Research to Improve Medication-Based Treatment (BRIM) program is to support research that assesses whether behavioral interventions can improve outcomes of medication-based treatment.

Specifically, the BRIM program seeks to test the effectiveness of combining medications with a wide range of evidence-based behavioral interventions in diverse groups of patients, including veterans, young adults, low-income individuals, and Latina and Native American women. The behavioral interventions include yoga and mindfulness, cognitive behavioral therapy, multidisciplinary rehabilitation, and mobile health technology.

Researchers hope to determine whether using these interventions in combination with medication improves adherence to medication, improves treatment outcomes, and reduces relapse in individuals seeking treatment for OUD.

Open Funding Opportunities

There are no Open Funding Opportunities at this time.

Research Examples

Some of the research projects will be carried out in the context of treatment services that the Substance Abuse and Mental Health Services Administration provides for OUD, layering additional research into state efforts to expand access to evidence-based treatment and recovery support services. 

Ongoing research includes:

  • Refining and adapting a successful telephone-based psychosocial pain management intervention in veterans with OUD and then evaluating its effectiveness in combination with medication
  • Testing mindful awareness in body-oriented therapy as an adjunct to medication in three clinical settings
  • Employing peer recovery coaches to support retention in medication-based treatment for low-income, minority individuals with OUD who live in urban settings
  • Adapting a cognitive behavioral therapy-based text message system to assist patients with OUD with medication adherence and treatment retention
  • Developing, testing, and comparing two behavioral economics interventions to promote adherence in patients initiating medication-based treatment
  • Evaluating the effects of assisted exercise and cognitive behavioral therapy as adjunctive treatments to medication in adults with OUD and chronic pain who are enrolled in residential treatment programs
  • Assessing efficacy of Mindfulness Oriented Recovery Enhancement (MORE), which simultaneously addresses chronic pain and opioid use disorder, in decreasing opioid relapse in individuals with co-occurring chronic pain and OUD
  • Refining and testing an intervention to address barriers to treatment engagement in vulnerable, young adults with OUD by messaging and collaborative planning with families
  • Evaluating the efficacy of computer-based training for cognitive behavioral therapy that emphasizes teaching cognitive and behavioral coping skills to increase retention in medication-based treatment for OUD
  • Establishing feasibility and testing efficacy of a peer-driven mentoring program to increase medicated-based treatment adherence for individuals being treated with medication for opioid use disorder 
  • Testing whether an online peer support community intervention can increase medication initiative and sustainment among participants with OUD who are recruited online
  • Assessing a mobile app that delivers interactive therapy lessons to teach participants cognitive-behavioral coping skills to resist drug use and to address factors such as craving, depression, and other mood problems in order to prevent relapse
  • Adapt, refine, and compare the effectiveness of gradually increased the dose a mindfulness-based intervention increase treatment retention and to reduce the impact of stress, anxiety, depression, and chronic pain in individuals engaged in MAT

  • Brandeis University – Massachusetts
  • Cambridge Health Alliance – Massachusetts
  • Case Western Reserve University – Ohio
  • Dartmouth College – New Hampshire
  • Maryland Treatment Centers – Maryland
  • Penn State Health Hershey Medical Center – Pennsylvania
  • Robert Wood Johnson Medical School – New Jersey
  • University of Alabama – Alabama
  • University of California, Irvine – California
  • University of California, Los Angeles – California
  • University of Colorado, Denver – Colorado
  • University of Maryland, College Park – Maryland
  • University of Michigan – Michigan
  • University of Tennessee Health Science Center – Tennessee
  • University of Washington – Washington

2021
Adapting the HOPE Online Support Intervention to Increase MAT Uptake Among OUD Patients
Oct 12, 2021
2020
OUD Stigma Mechanisms in the Context of Buprenorphine Treatment
Sep 29, 2020
2020
Behavioral Economics based stigma reduction intervention for low income, African American individuals with OUD
Sep 29, 2020
2020
Enhancing Exercise and Psychotherapy to Treat Comorbid Addiction
Sep 29, 2020
2020
Understanding How Peers Can Shift Stigma to Retain Low-Income, Minority Individuals in Opioid Treatment
Sep 29, 2020

NIH announces awards for behavioral research on OUD prevention and treatment

Six research awards totaling $9.4 million over three years will study the impact of behavioral interventions for primary or secondary prevention of opioid use disorder (OUD), or as a complement to medication-assisted treatment (MAT) of OUD.

Read more